As of March 15, 2023, Seychelles was the African country with the highest coronavirus (COVID-19) vaccination rate, with around 205 doses administered per 100 individuals. Mauritius and Rwanda followed with 201 and 190 doses per 100 people, respectively. Ranking fourth, Morocco had a vaccination rate of approximately 148 doses per 100 people, registering the third-highest number of inoculations after Egypt and Nigeria. In South Africa, the most affected country on the continent, the vaccination rate instead reached around 64 per 100 population.

How did Africa obtain the vaccines?

Vaccines in Africa were obtained in different ways. African nations both purchased new doses and received them from other countries. At the beginning of the vaccination campaigns, donations came from all over the world, such as China, the United Arab Emirates, India, and Russia. The United Nations-led COVAX initiative provided Oxford/AstraZeneca and Pfizer/BioNTech doses to several African countries. Within this program, the continent received nearly 270 million doses as of January 2022. Moreover, the vaccination campaign has also been an occasion for intra-African solidarity. Senegal has, for instance, donated vaccines to the Gambia, while in January 2021, Algeria announced that it would have shared its supply with Tunisia.

COVID-19 impact on the African economy

The spread of COVID-19 negatively affected socio-economic growth in Africa, with the continent’s Gross Domestic Product (GDP) contracting significantly in 2020. Specifically, Southern Africa experienced the sharpest decline, at minus six percent, followed by North Africa at minus 1.7 percent. Most of Africa’s key economic sectors were hit by the pandemic. The drop in global oil prices led to a crisis in the oil and gas sector. Nigeria, the continent’s leading oil-exporting country, witnessed a considerable decrease in crude oil trade in 2020. Moreover, the shrinking number of international tourist arrivals determined a loss of over 12 million jobs in Africa’s travel and tourism sector. Society has also been substantially affected by COVID-19 on the poorest continent in the world, and the number of people living in extreme poverty was estimated to increase by around 30 million in 2020.

The number of COVID-19 vaccination doses administered per 100 people in South Africa rose to 65 as of Oct 27 2023. This dataset includes a chart with historical data for South Africa Coronavirus Vaccination Rate.

As of March 6, 20212 South Africa had administered a total of close to 32.03 million doses of the coronavirus (COVID-19) vaccine. The country faced a rough start to its vaccination program as health authorities claimed that the beta variant (B.1.351 or 501Y.V2) was resistant against the received AstraZeneca/Oxford immunizing. South Africa then started February 17 its phase one campaign, vaccinating health workers with Johnson and Johnson vaccines. Gauteng, the province with Johannesburg as capital, had the highest number of vaccinated individuals at 9.02 million. Western Cape and KwaZulu-Natal followed with five million and 4.93 million jabs being administered. These were the same regions with the highest number of COVID-19 cases registered in the country.

Abstract

The COVID-19 Vaccine Survey (CVACS) is a South African national panel study of individuals initially unvaccinated against COVID-19. CVACS is implemented by the Southern Africa Labour and Development Research Unit (SALDRU) based at the University of Cape Town. The same respondents are interviewed twice, a few months apart, in 2021 and then 2022, to gather information about their attitudes, beliefs and intentions regarding COVID-19 vaccination. The purpose of CVACS is to collect high quality, timely, and relevant information on facilitators and barriers to COVID-19 vaccine uptake - including vaccine hesitancy and access constraints - to contribute to the development of data-driven campaigns and programmes to increase COVID-19 vaccination uptake in South Africa. In comparison to Survey 1, Survey 2 collected data on unvaccinated and vaccinated respondents. Final data files are: Unvaccinated (as was in S1) Vaccinated (New to S2) derived (As in S1) Link_File (New in S2 - this links the panel)

Geographic coverage

CVACS was not designed to be, and should not be used as a prevalence study. The data cannot be considered to be nationally representative of all unvaccinated individuals in South Africa.

Analysis unit

Households and individuals

Kind of data

Sample survey data [ssd]

Sampling procedure

CVACS Survey 1 was obtained from a stratified sample drawn from the GeoTerraImage (GTI) 2021 sampling frame (https://geoterraimage.com/), using individuals aged eighteen and older. The sample was primarily stratified across the following categories: province, population group, geographic area type (metro, non-metro urban, non-metro rural) and the neighbourhood lifestyle index (NLI), in groups of NLI 1-2, NLI 3-4, and NLI 5-10. Age categories defined according to the COVID-19 vaccination age groups (18-34, 35-49, 50-59, 60+), and gender were used as further explicit stratification variables. A credit bureau database was linked to this database at the enumeration area level, including individuals who had applied for credit, regardless of the outcome, and individuals who have had a credit check.

The CVACS Sample in Survey 2 included individuals from Survey 1 who were re-interviewed, who fell into two categories: vaccinated between Survey 1 and 2, or those remaining unvaccinated. In order to realise an unvaccinated sample of similar size to Survey 1, a top-up sample of unvaccinated individuals was interviewed. These individuals were drawn from the same sampling frame as Survey 1. Younger and female respondents were less likely to be re-interviewed in Survey 2. The full Survey 2 unvaccinated sample is more skewed to the younger age categories, due to higher vaccination rates among the elderly precluding many from inclusion into the study.

Mode of data collection

Computer Assisted Telephone Interview

Research instrument

Data was collected for Survey 2 with two questionnaires, one for vaccinated and one for unvaccinated respondents. CVACS used computer-assisted telephone interviews (CATI). The CVACS questionnaires were translated into all South African languages and interviews were conducted in the preferred language of the respondent. Most of the survey questions collected individual-level data, with some household level data also collected through the individual questionnaire.

Time series data for the statistic Immunization, measles (% of children ages 12-23 months) and country South Africa. Indicator Definition:Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.The indicator "Immunization, measles (% of children ages 12-23 months)" stands at 76.00 as of 12/31/2024, the lowest value since 12/31/2011. Regarding the One-Year-Change of the series, the current value constitutes a decrease of -5.00 percent compared to the value the year prior.The 1 year change in percent is -5.00.The 3 year change in percent is -12.64.The 5 year change in percent is -8.43.The 10 year change in percent is -9.52.The Serie's long term average value is 76.26. It's latest available value, on 12/31/2024, is 0.343 percent lower, compared to it's long term average value.The Serie's change in percent from it's minimum value, on 12/31/2003, to it's latest available value, on 12/31/2024, is +22.58%.The Serie's change in percent from it's maximum value, on 12/31/2021, to it's latest available value, on 12/31/2024, is -12.64%.

As of November 22, 2021, nearly 41 percent of the adult population in South Africa had already been fully vaccinated against the coronavirus (COVID-19). Western Cape had the highest vaccination rate among South African provinces, with 48.9 percent of its adult population being fully immunized. On the other hand, vaccination efforts in Gauteng were slower - around 37.4 percent of the population received both doses of the Pfizer vaccine or one dose of the J&J vaccine.

South Africa ZA: Immunization: Measles: % of Children Aged 12-23 Months data was reported at 60.000 % in 2017. This records a decrease from the previous number of 75.000 % for 2016. South Africa ZA: Immunization: Measles: % of Children Aged 12-23 Months data is updated yearly, averaging 70.000 % from Dec 1983 (Median) to 2017, with 35 observations. The data reached an all-time high of 85.000 % in 1993 and a record low of 60.000 % in 2017. South Africa ZA: Immunization: Measles: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s South Africa – Table ZA.World Bank.WDI: Health Statistics. Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Actual value and historical data chart for South Africa Immunization Measles Percent Of Children Ages 12 23 Months

As of November 17, 2022, Egypt had administered around 100 million coronavirus (COVID-19) vaccination doses, the highest number in Africa. Second in the ranking, Nigeria distributed ** million vaccines against the virus. South Africa, which accumulated the highest number of COVID-19 cases in the continent, carried out roughly ** million immunizations.

Africa still behind in the vaccination campaign

While *** doses of the COVID-19 vaccine have been administered per 100 people in the world, the vaccination rate in Africa is ** doses per 100 individuals. Besides being far slowest than the global average, the vaccination is marked by a striking divide between African countries. In February 2021, Africa started receiving vaccine supplies under the WHO-backed Covax facility. Additionally, some African nations purchased additional doses, while others were benefited from bilateral donations.

High acceptance of the coronavirus vaccine

While the COVID-19 vaccination still needs to gain pace in Africa, the majority of the continent’s population was willing to take a vaccine against the disease. According to a survey, nearly ** percent of Africans would get vaccinated, once the immunizing is considered safe and effective. However, one in four people believed a COVID-19 vaccine would be unsafe. Over *** million people in Africa were already infected by the virus since the beginning of the pandemic in March 2020.

Immunization against DPT of South Africa slumped by 7.06% from 85.0 % in 2022 to 79.0 % in 2023. Since the 2.38% rise in 2021, immunization against DPT dropped by 8.14% in 2023. Child immunization measures the percentage of children ages 12-23 months who received vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.

Context

The COVID-19 outbreak has brought the whole planet to its knees.More over 4.5 million people have died since the writing of this notebook, and the only acceptable way out of the disaster is to vaccinate all parts of society. Despite the fact that the benefits of vaccination have been proved to the world many times, anti-vaccine groups are springing up all over the world. This data set was generated to investigate the impact of coronavirus vaccinations on coronavirus mortality.

Content

country	iso_code	date	total_vaccinations	people_vaccinated	people_fully_vaccinated	New_deaths	population	ratio
country name	iso code for each country	date that this data belong	number of all doses of COVID vaccine usage in that country	number of people who got at least one shot of COVID vaccine	number of people who got full vaccine shots	number of daily new deaths	2021 country population	% of vaccinations in that country at that date = people_vaccinated/population * 100

Data Collection

This dataset is a combination of the following three datasets:

1.https://www.kaggle.com/gpreda/covid-world-vaccination-progress

2.https://covid19.who.int/WHO-COVID-19-global-data.csv

3.https://www.kaggle.com/rsrishav/world-population

you can find more detail about this dataset by reading this notebook:

https://www.kaggle.com/sinakaraji/simple-linear-regression-covid-vaccination

Countries in this dataset:

Afghanistan	Albania	Algeria	Andorra	Angola
Anguilla	Antigua and Barbuda	Argentina	Armenia	Aruba
Australia	Austria	Azerbaijan	Bahamas	Bahrain
Bangladesh	Barbados	Belarus	Belgium	Belize
Benin	Bermuda	Bhutan	Bolivia (Plurinational State of)	Brazil
Bosnia and Herzegovina	Botswana	Brunei Darussalam	Bulgaria	Burkina Faso
Cambodia	Cameroon	Canada	Cabo Verde	Cayman Islands
Central African Republic	Chad	Chile	China	Colombia
Comoros	Cook Islands	Costa Rica	Croatia	Cuba
Curaçao	Cyprus	Denmark	Djibouti	Dominica
Dominican Republic	Ecuador	Egypt	El Salvador	Equatorial Guinea
Estonia	Ethiopia	Falkland Islands (Malvinas)	Fiji	Finland
France	French Polynesia	Gabon	Gambia	Georgia
Germany	Ghana	Gibraltar	Greece	Greenland
Grenada	Guatemala	Guinea	Guinea-Bissau	Guyana
Haiti	Honduras	Hungary	Iceland	India
Indonesia	Iran (Islamic Republic of)	Iraq	Ireland	Isle of Man
Israel	Italy	Jamaica	Japan	Jordan
Kazakhstan	Kenya	Kiribati	Kuwait	Kyrgyzstan
Lao People's Democratic Republic	Latvia	Lebanon	Lesotho	Liberia
Libya	Liechtenstein	Lithuania	Luxembourg	Madagascar
Malawi	Malaysia	Maldives	Mali	Malta
Mauritania	Mauritius	Mexico	Republic of Moldova	Monaco
Mongolia	Montenegro	Montserrat	Morocco	Mozambique
Myanmar	Namibia	Nauru	Nepal	Netherlands
New Caledonia	New Zealand	Nicaragua	Niger	Nigeria
Niue	North Macedonia	Norway	Oman	Pakistan
occupied Palestinian territory, including east Jerusalem
Panama	Papua New Guinea	Paraguay	Peru	Philippines
Poland	Portugal	Qatar	Romania	Russian Federation
Rwanda	Saint Kitts and Nevis	Saint Lucia
Saint Vincent and the Grenadines	Samoa	San Marino	Sao Tome and Principe	Saudi Arabia
Senegal	Serbia	Seychelles	Sierra Leone	Singapore
Slovakia	Slovenia	Solomon Islands	Somalia	South Africa
Republic of Korea	South Sudan	Spain	Sri Lanka	Sudan
Suriname	Sweden	Switzerland	Syrian Arab Republic	Tajikistan
United Republic of Tanzania	Thailand	Togo	Tonga	Trinidad and Tobago
Tunisia	Turkey	Turkmenistan	Turks and Caicos Islands	Tuvalu
Uganda	Ukraine	United Arab Emirates	The United Kingdom	United States of America
Uruguay	Uzbekistan	Vanuatu	Venezuela (Bolivarian Republic of)	Viet Nam
Wallis and Futuna	Yemen	Zambia	Zimbabwe

South Africa ZA: Immunization: DPT: % of Children Aged 12-23 Months data was reported at 66.000 % in 2016. This records a decrease from the previous number of 75.000 % for 2015. South Africa ZA: Immunization: DPT: % of Children Aged 12-23 Months data is updated yearly, averaging 73.500 % from Dec 1983 (Median) to 2016, with 34 observations. The data reached an all-time high of 82.000 % in 2007 and a record low of 65.000 % in 2012. South Africa ZA: Immunization: DPT: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s South Africa – Table ZA.World Bank: Health Statistics. Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

76.0 (%) in 2024. Child immunization measures the percentage of children ages 12-23 months who received vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.

Actual value and historical data chart for South Africa Immunization Bcg Percent Of One Year Old Children

Morbidity and mortality attributable to COVID-19 is devastating global health systems and economies. Bacillus Calmette Guérin (BCG) vaccination has been in use for many decades to prevent severe forms of tuberculosis in children. Studies have also shown a combination of improved long-term innate or trained immunity (through epigenetic reprogramming of myeloid cells) and adaptive responses after BCG vaccination, which leads to non-specific protective effects in adults. Observational studies have shown that countries with routine BCG vaccination programs have significantly less reported cases and deaths of COVID-19, but such studies are prone to significant bias and need confirmation. To date, in the absence of direct evidence, WHO does not recommend BCG for the prevention of COVID-19. This project aims to investigate in a timely manner whether and why BCG-revaccination can reduce infection rate and/or disease severity in health care workers during the SARS-CoV-2 outbreak in South Africa. These objectives will be achieved with a blinded, randomised controlled trial of BCG revaccination versus placebo in exposed front-line staff in hospitals in Cape Town. Observations will include the rate of infection with COVID-19 as well as the occurrence of mild, moderate or severe ambulatory respiratory tract infections, hospitalisation, need for oxygen, mechanical ventilation or death. HIV-positive individuals will be excluded. Safety of the vaccines will be monitored. A secondary endpoint is the occurrence of latent or active tuberculosis. Initial sample size and follow-up duration is at least 500 workers and 52 weeks. Statistical analysis will be model-based and ongoing in real time with frequent interim analyses and optional increases of both sample size or observation time, based on the unforeseeable trajectory of the South African COVID-19 epidemic, available funds and recommendations of an independent data and safety monitoring board. The study will be supported by a novel 3D lung organoid model of SARS-CoV-2 infection system that can mimic the cascade of immunological events after SARS-CoV-2 infection to determine and analyse the contribution of cellular components to the impact of BCG revaccination in this study. Given the immediate threat of the SARS-CoV-2 epidemic the trial has been designed as a pragmatic study with highly feasible endpoints that can be continuously measured. This allows for the most rapid identification of a beneficial outcome that would lead to immediate dissemination of the results, vaccination of the control group and outreach to the health authorities to consider BCG vaccination for all qualifying health care workers. Methods This dataset was collected in a clinical randomised control trial under the TASK008-BCG CORONA protocol. The trial was conducted in South Africa. This trial was registered with ClinicalTrials.gov, NCT04379336.

South Africa ZA: Immunization: HepB3: % of One-Year-Old Children data was reported at 66.000 % in 2016. This records a decrease from the previous number of 75.000 % for 2015. South Africa ZA: Immunization: HepB3: % of One-Year-Old Children data is updated yearly, averaging 74.000 % from Dec 1997 (Median) to 2016, with 20 observations. The data reached an all-time high of 83.000 % in 2007 and a record low of 66.000 % in 2016. South Africa ZA: Immunization: HepB3: % of One-Year-Old Children data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s South Africa – Table ZA.World Bank: Health Statistics. Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

79.0 (%) in 2023. Child immunization measures the percentage of children ages 12-23 months who received vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.

Around **** percent of Africa's population was fully vaccinated against the coronavirus (COVID-19) as of July 11, 2022. Over *** million vaccine doses have been administered on the continent since the beginning of the vaccination campaign in 2021. In general, Africa's vaccination rate is far lower than the global average.

Actual value and historical data chart for South Africa Immunization Dpt Percent Of Children Ages 12 23 Months

To estimate intention to receive newly introduced adult vaccines among community members and healthcare workers (HCWs) in Lusaka, Zambia in the context of previous COVID-19 vaccine uptake and perceived disease threat and, identify trusted sources of vaccine information. We conducted a cross-sectional survey among a random sample of community members and a convenience sample of HCWs from 13 November to 15 December 2023. We evaluated future vaccination intentions by self-reported COVID-19 vaccine uptake, community role, vaccine type (COVID-19 booster, HIV, tuberculosis, malaria, pneumonia, diarrheal disease), and source of information using adjusted, mixed effects Poisson regression and adjusted probability models. We enrolled 395 (79.2 %) community members and 104 (20.8 %) HCWs (N = 499). There was high intention to receive new vaccines among community members (mean score = 83.6 %) andHCWs (mean score = 86.0 %), though intentions varied by vaccine type. Prior COVID-19 vaccine uptake (0,..., Study design We conducted a cross-sectional survey in Lusaka, Zambia, recruiting community members from randomly selected households in four urban communities with relatively low COVID-19 vaccine uptake and healthcare workers (HCWs) at ten healthcare facilities chosen for diversity in size and geographic location. All participants were recruited from November to December 2023, long after the major COVID-19 waves in southern Africa, including the 2021 Omicron wave that was first reported in South Africa and Botswana. Participants and recruitment strategy Adults aged 18 years and above who resided in Lusaka Province and could provide consent were eligible to participate in the study. For HCWs, eligibility was restricted to those providing direct clinical services to patients or community-based health services. We purposively selected 10 healthcare facilities to recruit HCWs and four high-density, low-income areas (compounds) with low COVID-19 vaccination rates to recruit community members..., , # Intention to receive new vaccines post-COVID-19 pandemic among adults and health workers in Lusaka, Zambia

https://doi.org/10.5061/dryad.z08kprrqk

Description of the data and file structure

Files and variables

File: intent_novel_vaccine-06feb2025_share.csv

Description:Â Dataset used in the analyses found in the Vaccine article entitled "Intention to receive new vaccines post-COVID-19 pandemic among adults and health workers in Lusaka, Zambia" (here).

Variables

• gender: birth sex
• age_cat6: categorical age (six categories)
• hcw_alt: community member [0] or healthcare work (HCW) [1]
• marital: marital status
• religion: reported religion
• educ_cat: education categorically
• employ_cat: employment status categorically
• income_qtile: income quartile
• cov_rev: reported receipt of COVID-19 vaccine
• hiv: HIV status
• intent_flu_alt: intention...,